Igal Ladabaum

Igal Ladabaum is a Co-Founder and serves as Board Member and Chief Executive Officer at Hospi. He also serves as Executive Chairman at Attune Medical. He is an experienced medical device executive and an engineer with over 28 issued patents. Prior to co-founding Hospi, Igal was the General Manager of Sonova's InSound Center of Competence, an innovation center for hearing aid technology. He led the engineering and clinical research team that brought the Lyric hearing aid to market. Lyric's success resulted in the acquisition of InSound Medical by Sonova in 2010 with total transaction proceeds of $200 million. Prior to his work at InSound, Igal Ladabaum was the co-founding Chief Executive Officer and Chief Technical Officer of Sensant Corporation, a company that introduced the first fundamental change in ultrasonic transduction in decades. After an acquisition by Siemens in 2005, Igal led Siemens Ultrasound Engineering division and was a member of that division's leadership circle. Igal was also an early investor and a board member of Ornim, a patient monitoring company. After Orbimed led a successful $19 million investment round in Ornim in 2012, Igal left his board position to focus on Hospi. Igal also serves as a Director on the board of Radlogics, Inc., which provides software solutions for radiologists. Igal was educated at U.C. Berkeley, The Ecole Polytechnique, and Stanford University.